Apoptosis‐inducing factor (AIF) plays a dual role in regulating cell survival and apoptosis,
acting as a prosurvival factor in mitochondria via its NADH oxidoreductase activity and …

Esophageal squamous cell carcinoma (ESCC) is a common malignancy with poor
prognosis. The drug resistance compromises the efficacy of chemotherapy for ESCC. Long …

Esophageal cancer is one of the leading causes of cancer‐related deaths worldwide.
FAM225A is a novel lncRNA, only has been explored in nasopharyngeal carcinoma …

Cisplatin, as one of the front-line chemotherapeutic drugs, is employed for the treatment of
esophageal squamous cell carcinoma (ESCC). However, the occurrence of cisplatin …

Cisplatin (CDDP) is one of the front-line chemotherapeutic drugs used in the treatment of
esophageal squamous cell carcinoma (ESCC). Occurrence of resistance to CDDP has …

Esophageal squamous cell carcinoma (ESCC) is one of the most common malignancies
worldwide with a low 5‑year survival rate due to the lack of effective therapeutic strategies …

Acquired resistance to cisplatin (CDDP) in esophageal squamous cell carcinoma (ESCC)
remains a major challenge in cancer therapy. Although progress has been made in …

Most patients diagnosed with thoracic esophageal squamous cell carcinoma (ESCC) have
progressed beyond surgical resection as a therapeutic option. Difficulties in the proper …

Background Although the current treatment for esophageal cancer has great technological
progress, the 5-year survival rate of patients is not optimistic. About 70% of patients with …

Introducción: El cáncer de esófago representa la séptima neoplasia más frecuente y la sexta
causa de muerte por cáncer a nivel mundial. Debido a su historia natural, suele …